COMMUNIQUÉS West-GlobeNewswire

SK pharmteco Launches Catalyst Kit to Streamline Catalytic Reaction Development and Continuous Manufacturing Scale-Up
24/09/2026
New structured offering bridges the gap between catalyst screening, process optimization, and commercial-scale continuous flow manufacturing for RSMs, Intermediates, and APIs RANCHO CORDOVA, Calif., Sept. 24, 2026 ( [...]
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
24/09/2026
Plan combines up to $25 million in new capital with restructuring of $3 million in existing debt to support commercial execution and manufacturing expansion Company anticipates positive monthly operating cash flow by [...]
ŌURA Joins Workday Wellness, Giving Employers a New Way to Fund Oura Ring as a Flexible Benefit
24/09/2026
Employers can now fully fund, subsidize, or discount the world's leading smart ring for their workforce through Workday Benefits & Wellness SAN FRANCISCO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ŌURA, a leading health [...]
Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting
24/09/2026
NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system [...]
Hyperion DeFi Supports DoubleZero Edge in Launching the Fastest Commercially Available Hyperliquid Data Feeds
24/09/2026
DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced its first initiative to bring an infrastructure team from another blockchain into the [...]
Chiropractic Founders Day highlights nearly a century of care, paves way for National Upper Cervical Care Association's continued commitment to precise patient care in spinal health
24/09/2026
SAN DIEGO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Each year, Chiropractic Founders Day is celebrated on Sept. 18, reminding the chiropractic community of the life-changing benefits it brings to millions worldwide. The date [...]
NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst
24/09/2026
DENVER, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has picked up fresh Wall Street coverage at a pivotal moment for its experimental brain-cancer pipeline. [...]
Ritedose Positioned to Support Hospitals with Reliable and Quality Albuterol Inhalation Solution, USP 0.5% (Albuterol Concentrate) Supply
24/09/2026
Ritedose expands albuterol inhalation solution production and strengthens its role as a trusted source for inhaled solutions The Company ramped up multiple albuterol inhalation solution strengths during national [...]
Easy Environmental Solutions Participates in International Roundtable at United Nations Headquarters During Climate Week NYC
24/09/2026
Company advances international relationships around localized fertilizer production, agricultural resilience, and commercial infrastructure development MANKATO, Minn. and NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- [...]
Coloplast A/S - Financial Calendar 2026/27
24/09/2026
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/ Kind regards, Investor Relations [...]
Adventure With a Purpose: A Race Against Blindness Unveils Adventure Package Fundraiser Valued at $350,000
24/09/2026
One winner will receive a luxury Entegra Super C motorhome, Polaris XPEDITION, trailer, and $100,000 cash GILBERT, Ariz., Sept. 24, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness has launched one of the largest [...]
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
24/09/2026
Biodesix-led tumor-informed and tumor-naïve programs draw on the company’s bioinformatics and diagnostics test development expertise LOUISVILLE, Colo., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a [...]
aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
24/09/2026
Global Phase 3 study will evaluate efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease utilizing FVC as primary endpoint. Company expects to initiate study-related activities in the fourth [...]
MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)
24/09/2026
LA JOLLA, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis
24/09/2026
Topline durability data reinforce potential for single-dose miv-cel to free patients from life-long disease burden and chronic immunotherapies, further highlighting miv-cel’s differentiated construct Sustained clinical [...]
Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product
24/09/2026
NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received approval from the [...]
PridCor Therapeutics Advances Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID Toward Enrollment
24/09/2026
SHIELD Phase 2 Study: first payment made under the clinical trial agreement with Mount Sinai and study drug ordered; the randomized, double-blind, placebo-controlled study, registered as NCT07597902, plans to enroll [...]
Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million
24/09/2026
JUPITER, Fla., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it has entered into a financing agreement with AvenCell Therapeutics, Inc., a clinical-stage cell [...]
Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder
24/09/2026
Exploratory research results presented at Psych Congress 2026 in New Orleans Full poster presentation can be found on “Publications” section of Company’s website SOUTH SAN FRANCISCO, Calif., Sept. 24, 2026 (GLOBE [...]

Pages